art_1__para

The purpose of this Regulation is to lay down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and to establish a European Agency for the Evaluation of Medicinal Products. The provisions of this Regulation shall not affect the powers of the Member States' authorities as regards the price setting of medicinal products or their inclusion in the scope of the national health system of the Member States' authorities or their inclusion in the scope of the social security schemes on the basis of health, economic and social conditions. For example, the Member States may choose from the marketing authorization those therapeutic indications and pack sizes which will be covered by their social security organizations.

2 national measures recorded under this provision, in 1 form — sign in to view the analysis.

← Article 1 · All articles · Article 2 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.